Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Oncology
Reference61 articles.
1. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
2. Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma
3. Renal cell carcinoma: etiology, incidence and epidemiology
4. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study
5. Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma;Biomedicines;2024-05-16
2. Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy;European Urology Open Science;2024-05
3. A Systematic Review of Treatment-Related Adverse Events for Combination Therapy of Multiple Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor;Cancer Control;2024-01
4. Mathematical and Machine Learning Models of Renal Cell Carcinoma: A Review;Bioengineering;2023-11-16
5. Radiomics and Ki-67 index predict survival in clear cell renal cell carcinoma;The British Journal of Radiology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3